Bohrmann B, Baumann K, Benz J, Gerber F, Huber W, Knoflach F, Messer J, Oroszlan K, Rauchenberger R, Richter WF, Rothe C, Urban M, Bardroff M, Winter M, Nordstedt C, Loetscher H. Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β. J Alzheimers Dis. 2012;28(1):49-69. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Aβ Antibody Gantenerumab Clears Plaques
  2. First Stab at Combination Therapy Yields Additive Effect
  3. Brain Shuttle Ferries Antibodies Across the Blood-Brain Barrier
  4. Shape of a Hug: How the Embrace of a Therapeutic Aβ Antibody Really Matters
  5. TREM2 Helps Phagocytes Gobble Up Aβ Coated in Antibodies

Therapeutics

  1. Gantenerumab